US2023416671A1PendingUtilityA1
Composition And Method For Stabilizing And Maintaining The Viability Of Hardy Microorganisms
Est. expiryMay 27, 2034(~7.9 yrs left)· nominal 20-yr term from priority
Inventors:H. Chaim BirnboimCassandra Kelly-CirinoBitapi RayJacques Oscar Everard NilesOlle Maarten De Bruin
C12Q 1/04C12N 1/20C12Q 1/00C12N 1/04C12Q 1/24
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present application is to provide a composition and method for stabilizing and maintaining the viability of hardy microorganisms from sample collection to downstream analysis. In particular, there is a method for preserving viable hardy bacteria, such as Mycobacteria, Bacillus anthracis , or Clostridium difficile , in a biological sample, comprising contacting the biological sample with a stabilization composition, wherein the stabilization composition comprises a chelating agent, a denaturing, a salt and has a p H between about 6 and about 11.
Claims
exact text as granted — not AI-modified1 . A method for stabilizing the microbiome within a biological sample comprising contacting the biological sample with a stabilization composition, wherein the stabilization composition comprises a chelating agent, a denaturing agent, a salt and has a pH between 6 and 11.
2 . The method of claim 1 , wherein the biological sample is a mucoid biological fluid.
3 . The method of claim 2 wherein the mucoid biological fluid is sputum or saliva.
4 . The method of claim 1 , wherein the composition comprises one or more of the following characteristics:
(a) the chelating agent is ethylene glycol tetraacetic acid (EGTA), (2-Hydroxyethyl)ethylenediaminetriacetic acid (HEDTA), diethylene triamine pentaacetic acid (DTPA), nitrilotriacetic acid (NTA), ethylenediaminetriacetic acid (EDTA), cyclohexanediaminetetraacetic acid (CDTA), N,N-bis(carboxymethyl)glycine, citrate anhydrous, sodium citrate, calcium citrate, ammonium citrate, ammonium bicitrate, citric acid, diammonium citrate, ferric ammonium citrate, lithium citrate, or any combination thereof; (b) the denaturing agent is an anionic detergent, a cationic detergent or a nonionic detergent; and (c) the composition comprises: (i) 2% SDS, 12.5 mM CDTA, 250 mM LiCl, 50 mM glycine and has pH 10.5; or (ii) 4% SDS, 50 mM CDTA, 250 mM LiCl, 140 mM LiOH and has pH 6.8.
5 . The method of claim 4 wherein the anionic detergent is sodium dodecyl sulfate (SDS), lithium dodecyl sulphate or sodium lauroyl sulfate (SLS).
6 . The method of claim 4 wherein the cationic detergent is cetyltrimethyl ammonium bromide (CTAB).
7 . The method of claim 4 wherein the nonionic detergent is Tween-20™, Triton X-100™, or Brij-58™.
8 . The method of claim 1 , wherein the stabilization composition preserves, in a viable state, hardy bacteria in a biological sample and reduces or eliminates other microbial growth in the sample.
9 . A method for characterization of bacterial nucleic acid from viable hardy bacteria in a biological sample comprising said viable hardy bacteria, comprising:
contacting the biological sample with a stabilization composition, wherein the stabilization composition comprises a chelating agent, a denaturing agent, a salt and has a pH between 6 and 11; and amplifying the nucleic acid in the sample, wherein the level of amplified nucleic acid remains substantially unchanged if the amplification step occurs immediately after collection, or later.
10 . The method of claim 9 , wherein the biological sample is a mucoid biological fluid.
11 . The method of claim 10 wherein the mucoid biological fluid is sputum or saliva.
12 . The method of claim 9 , wherein the composition comprises one or more of the following characteristics:
(a) the chelating agent is ethylene glycol tetraacetic acid (EGTA), (2-Hydroxyethyl)ethylenediaminetriacetic acid (HEDTA), diethylene triamine pentaacetic acid (DTPA), nitrilotriacetic acid (NTA), ethylenediaminetriacetic acid (EDTA), cyclohexanediaminetetraacetic acid (CDTA), N,N-bis(carboxymethyl)glycine, citrate anhydrous, sodium citrate, calcium citrate, ammonium citrate, ammonium bicitrate, citric acid, diammonium citrate, ferric ammonium citrate, lithium citrate, or any combination thereof; (b) the denaturing agent is an anionic detergent, a cationic detergent or a nonionic detergent; and (c) the composition comprises: (i) 2% SDS, 12.5 mM CDTA, 250 mM LiCl, 50 mM glycine and has pH 10.5; or (ii) 4% SDS, 50 mM CDTA, 250 mM LiCl, 140 mM LiOH and has pH 6.8.
13 . The method of claim 12 wherein the anionic detergent is sodium dodecyl sulfate (SDS), lithium dodecyl sulphate or sodium lauroyl sulfate (SLS).
14 . The method of claim 12 wherein the cationic detergent is cetyltrimethyl ammonium bromide (CTAB).
15 . The method of claim 12 wherein the nonionic detergent is Tween-20™, Triton X-100™, or Brij-58™.
16 . A composition comprising:
a chelating agent; a denaturing agent; and viable hardy microorganisms.
17 . The composition of claim 16 , wherein the composition comprises one or more characteristics:
(a) the chelating agent is ethylene glycol tetraacetic acid (EGTA), (2-Hydroxyethyl)ethylenediaminetriacetic acid (HEDTA), diethylene triamine pentaacetic acid (DTPA), nitrilotriacetic acid (NTA), ethylenediaminetriacetic acid (EDTA), cyclohexanediaminetetraacetic acid (CDTA), N,N-bis(carboxymethyl)glycine, citrate anhydrous, sodium citrate, calcium citrate, ammonium citrate, ammonium bicitrate, citric acid, diammonium citrate, ferric ammonium citrate, lithium citrate, or any combination thereof; (b) the denaturing agent is an anionic detergent, a cationic detergent, or a nonionic detergent; and (c) the composition comprises: (i) 2% SDS, 12.5 mM CDTA, 250 mM LiCl, 50 mM glycine and has pH 10.5; or (ii) 4% SDS, 50 mM CDTA, 250 mM LiCl, 140 mM LiOH and has pH 6.8.
18 . The method of claim 17 wherein the anionic detergent is sodium dodecyl sulfate (SDS), lithium dodecyl sulphate or sodium lauroyl sulfate (SLS).
19 . The method of claim 17 wherein the cationic detergent is cetyltrimethyl ammonium bromide (CTAB).
20 . The method of claim 17 wherein the nonionic detergent is Tween-20™, Triton X-100™, or Brij-58™.
21 . The composition of claim 16 , wherein the hardy microorganism is a Mycobacteria, Bacillus anthracis , or Clostridium difficile.
22 . The composition of claim 21 , wherein the Mycobacteria is Mycobacterium tuberculosis and wherein the Bacillus anthracis is in the form of spores.Join the waitlist — get patent alerts
Track US2023416671A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.